Kuroki H
Department of Pediatrics, Chiba University School of Medicine.
Rinsho Byori. 2000 Jan;Suppl 111:125-31.
S. pneumoniae is one of the most important pathogens in respiratory tract infections and systemic infections. The frequencies of isolating Penicillin-resistant Streptococcus pneumoniae(PRSP) has been increasing recently. The therapeutic strategy is becoming difficult. Ampicillin and amoxicillin are the choices of drugs to treat respiratory infections with intermediate strains. Panipenem may be the first choice of treatment for systemic infections. Administration of vancomycin should also be considered. Judicious use of antimicrobials is necessary to avoid the spread of multi-resistant strains. In some cases physical therapy would be recommended.
肺炎链球菌是呼吸道感染和全身感染中最重要的病原体之一。近年来,耐青霉素肺炎链球菌(PRSP)的分离频率一直在上升。治疗策略变得困难。氨苄西林和阿莫西林是治疗中度菌株引起的呼吸道感染的药物选择。帕尼培南可能是全身感染治疗的首选。也应考虑使用万古霉素。明智地使用抗菌药物对于避免多重耐药菌株的传播是必要的。在某些情况下,建议进行物理治疗。